United States Acne Drugs Industry 2016 Deep Market Research Report

1 Industry Overview

1.1 Definition and Specifications of Acne Drugs

1.2 Classification of Acne Drugs

1.3 Applications of Acne Drugs

1.4 Industry Chain Structure of Acne Drugs

1.5 Industry Overview of Acne Drugs

1.6 Industry Policy Analysis of Acne Drugs

1.7 Industry News Analysis of Acne Drugs

2 Manufacturing Cost Structure Analysis of Acne Drugs

2.1 Bill of Materials (BOM) of Acne Drugs

2.2 BOM Price Analysis of Acne Drugs

2.3 Labor Cost Analysis of Acne Drugs

2.4 Depreciation Cost Analysis of Acne Drugs

2.5 Manufacturing Cost Structure Analysis of Acne Drugs

2.6 Manufacturing Process Analysis of Acne Drugs

2.7 United States Price, Cost and Gross of Acne Drugs 2011-2016

3 Technical Data and Manufacturing Plants Analysis

3.1 Capacity and Commercial Production Date of United States Key Manufacturers in 2015

3.2 Manufacturing Plants Distribution of United States Key Acne Drugs Manufacturers in 2015

3.3 R&D Status and Technology Source of United States Acne Drugs Key Manufacturers in 2015

3.4 Raw Materials Sources Analysis of United States Acne Drugs Key Manufacturers in 2015

4 Production Analysis of Acne Drugs by Regions, Type, and Applications

4.1 United States Production of Acne Drugs by Regions 2011-2016

4.2 United States Production of Acne Drugs by Type 2011-2016

4.3 United States Sales of Acne Drugs by Applications 2011-2016

4.4 Price Analysis of United States Acne Drugs Key Manufacturers in 2015

4.5 United States Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Acne Drugs 2011-2016

5 Consumption Volume and Consumption Value Analysis of Acne Drugs by Regions

5.1 United States Consumption Volume of Acne Drugs by Regions 2011-2016

5.2 United States Consumption Value of Acne Drugs by Regions 2011-2016

5.3 United States Consumption Price Analysis of Acne Drugs by Regions 2011-2016

6 Analysis of Acne Drugs Production, Supply, Sales and Market Status 2011-2016

6.1 Capacity, Production, Sales, and Revenue of Acne Drugs 2011-2016

6.2 Production Market Share and Sales Market Share Analysis of Acne Drugs 2014-2015

6.3 Sales Overview of Acne Drugs 2011-2016

6.4 Supply, Consumption and Gap of Acne Drugs 2011-2016

6.5 Import, Export and Consumption of Acne Drugs 2011-2016

6.6 Cost, Price, Revenue and Gross Margin of Acne Drugs 2011-2016

7 Analysis of Acne Drugs Industry Key Manufacturers

7.1 Pfizer

7.1.1 Company Profile

7.1.2 Product Picture and Specification

7.1.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.1.4 Pfizer SWOT Analysis

7.2 Galderma

7.2.1 Company Profile

7.2.2 Product Picture and Specification

7.2.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.2.4 Galderma SWOT Analysis

7.3 Stiefel

7.3.1 Company Profile

7.3.2 Product Picture and Specification

7.3.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.3.4 Stiefel SWOT Analysis

7.4 Valeant

7.4.1 Company Profile

7.4.2 Product Picture and Specification

7.4.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.4.4 Valeant SWOT Analysis

7.5 Bayer HealthCare

7.5.1 Company Profile

7.5.2 Product Picture and Specification

7.5.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.5.4 Bayer HealthCare SWOT Analysis

7.6 AndroScience

7.6.1 Company Profile

7.6.2 Product Picture and Specification

7.6.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.6.4 AndroScience SWOT Analysis

7.7 GlaxoSmithKline

7.7.1 Company Profile

7.7.2 Product Picture and Specification

7.7.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.7.4 GlaxoSmithKline SWOT Analysis

7.8 Johnson & Johnson

7.8.1 Company Profile

7.8.2 Product Picture and Specification

7.8.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.8.4 Johnson & Johnson SWOT Analysis

7.9 Roche

7.9.1 Company Profile

7.9.2 Product Picture and Specification

7.9.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.9.4 Roche SWOT Analysis

7.10 Foamix

7.10.1 Company Profile

7.10.2 Product Picture and Specification

7.10.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.10.4 Foamix SWOT Analysis

7.11 Promius Pharma

7.11.1 Company Profile

7.11.2 Product Picture and Specification

7.11.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.11.4 Promius Pharma SWOT Analysis

7.12 Teva

7.12.1 Company Profile

7.12.2 Product Picture and Specification

7.12.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.12.4 Teva SWOT Analysis

7.13 Roche

7.13.1 Company Profile

7.13.2 Product Picture and Specification

7.13.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.13.4 Roche SWOT Analysis

7.14 Anterios

7.14.1 Company Profile

7.14.2 Product Picture and Specification

7.14.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.14.4 Anterios SWOT Analysis

7.15 Aqua Pharmaceuticals

7.15.1 Company Profile

7.15.2 Product Picture and Specification

7.15.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.15.4 Aqua Pharmaceuticals SWOT Analysis

7.16 Astellas

7.16.1 Company Profile

7.16.2 Product Picture and Specification

7.16.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.16.4 Astellas SWOT Analysis

7.17 BioPharmX

7.17.1 Company Profile

7.17.2 Product Picture and Specification

7.17.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.17.4 BioPharmX SWOT Analysis

7.18 Celtaxsys

7.18.1 Company Profile

7.18.2 Product Picture and Specification

7.18.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.18.4 Celtaxsys SWOT Analysis

7.19 Cipher Pharmaceuticals

7.19.1 Company Profile

7.19.2 Product Picture and Specification

7.19.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.19.4 Cipher Pharmaceuticals SWOT Analysis

7.20 COSMO Pharmaceuticals

7.20.1 Company Profile

7.20.2 Product Picture and Specification

7.20.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.20.4 COSMO Pharmaceuticals SWOT Analysis

7.21 Dermira

7.21.1 Company Profile

7.21.2 Product Picture and Specification

7.21.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.21.4 Dermira SWOT Analysis

7.22 Elorac

7.22.1 Company Profile

7.22.2 Product Picture and Specification

7.22.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.22.4 Elorac SWOT Analysis

7.23 Guthy-Renker

7.23.1 Company Profile

7.23.2 Product Picture and Specification

7.23.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.23.4 Guthy-Renker SWOT Analysis

7.24 Helix BioMedix

7.24.1 Company Profile

7.24.2 Product Picture and Specification

7.24.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.24.4 Helix BioMedix SWOT Analysis

7.25 Hygeia Therapeutics

7.25.1 Company Profile

7.25.2 Product Picture and Specification

7.25.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.25.4 Hygeia Therapeutics SWOT Analysis

7.26 Meda

7.26.1 Company Profile

7.26.2 Product Picture and Specification

7.26.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.26.4 Meda SWOT Analysis

7.27 Mylan

7.27.1 Company Profile

7.27.2 Product Picture and Specification

7.27.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.27.4 Mylan SWOT Analysis

7.28 Novan

7.28.1 Company Profile

7.28.2 Product Picture and Specification

7.28.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.28.4 Novan SWOT Analysis

7.29 Oculus Innovative Sciences

7.29.1 Company Profile

7.29.2 Product Picture and Specification

7.29.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.29.4 Oculus Innovative Sciences SWOT Analysis

7.30 Paratek Pharmaceuticals

7.30.1 Company Profile

7.30.2 Product Picture and Specification

7.30.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.30.4 Paratek Pharmaceuticals SWOT Analysis

7.31 Photocure

7.31.1 Company Profile

7.31.2 Product Picture and Specification

7.31.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.31.4 Photocure SWOT Analysis

7.32 Ranbaxy

7.32.1 Company Profile

7.32.2 Product Picture and Specification

7.32.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.32.4 Ranbaxy SWOT Analysis

7.33 Reckitt Benckiser

7.33.1 Company Profile

7.33.2 Product Picture and Specification

7.33.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.33.4 Reckitt Benckiser SWOT Analysis

7.34 Skinvisible Pharmaceuticals

7.34.1 Company Profile

7.34.2 Product Picture and Specification

7.34.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.34.4 Skinvisible Pharmaceuticals SWOT Analysis

7.35 Versapharm

7.35.1 Company Profile

7.35.2 Product Picture and Specification

7.35.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.35.4 Versapharm SWOT Analysis

7.36 XBiotech

7.36.1 Company Profile

7.36.2 Product Picture and Specification

7.36.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.36.4 XBiotech SWOT Analysis

8 Price and Gross Margin Analysis

8.1 Analysis of Price

8.2 Gross Margin Analysis

8.3 Price Comparison by Regions

8.4 Price Analysis of Different Acne Drugs Product Types

8.5 Market Share Analysis of Different Acne Drugs Price Levels

8.6 Gross Margin Analysis of Different Acne Drugs Applications

9 Marketing Trader or Distributor Analysis of Acne Drugs

9.1 Marketing Channels Status of Acne Drugs

9.2 Traders or Distributors of Acne Drugs with Contact Information

9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Acne Drugs

9.4 United States Import, Export and Trade Analysis of Acne Drugs

10 Development Trend of Acne Drugs Industry 2016-2021

10.1 Capacity and Production Overview of Acne Drugs 2016-2021

10.2 Production Market Share by Product Types of Acne Drugs 2016-2021

10.3 Sales and Sales Revenue Overview of Acne Drugs 2016-2021

10.4 United States Sales of Acne Drugs by Applications 2016-2021

10.5 Import, Export and Consumption of Acne Drugs 2016-2021

10.6 Cost, Price, Revenue and Gross Margin of Acne Drugs 2016-2021

11 Industry Chain Suppliers of Acne Drugs with Contact Information

11.1 Major Raw Materials Suppliers of Acne Drugs with Contact Information

11.2 Manufacturing Equipment Suppliers of Acne Drugs with Contact Information

11.3 Major Players of Acne Drugs with Contact Information

11.4 Key Consumers of Acne Drugs with Contact Information

11.5 Supply Chain Relationship Analysis of Acne Drugs

12 New Project Investment Feasibility Analysis of Acne Drugs

12.1 New Project SWOT Analysis of Acne Drugs

12.2 New Project Investment Feasibility Analysis of Acne Drugs

13 Conclusion of the United States Acne Drugs Industry 2016 Market Research Report

Figure Picture of Acne Drugs

Table Product Specifications of Acne Drugs

Table Classification of Acne Drugs

Figure United States Sales Market Share of Acne Drugs by Product Types in 2015

Table Applications of Acne Drugs

Figure United States Sales Market Share of Acne Drugs by Applications in 2015

Figure Industry Chain Structure of Acne Drugs

Table United States Industry Overview of Acne Drugs

Table Industry Policy of Acne Drugs

Table Industry News List of Acne Drugs

Table Bill of Materials (BOM) of Acne Drugs

Table Bill of Materials (BOM) Price of Acne Drugs

Table Labor Cost of Acne Drugs

Table Depreciation Cost of Acne Drugs

Table Manufacturing Cost Structure Analysis of Acne Drugs in 2015

Figure Manufacturing Process Analysis of Acne Drugs

Table United States Price Analysis of Acne Drugs 2011-2016 (USD/Dose)

Table United States Cost Analysis of Acne Drugs 2011-2016 (USD/Dose)

Table United States Gross Analysis of Acne Drugs 2011-2016

Table Capacity (K Doses) and Commercial Production Date of United States Acne Drugs Key Manufacturers in 2015

Table Manufacturing Plants Distribution of United States Key Acne Drugs Manufacturers in 2015

Table R&D Status and Technology Source of United States Acne Drugs Key Manufacturers in 2015

Table Raw Materials Sources Analysis of United States and United States Acne Drugs Key Manufacturers in 2015

Table United States Production of Acne Drugs by Regions 2011-2016 (K Doses)

Table United States Production Market Share of Acne Drugs by Regions 2011-2016

Figure United States Production Market Share of Acne Drugs by Regions in 2014

Figure United States Production Market Share of Acne Drugs by Regions in 2015

Table United States Production of Acne Drugs by Types in 2011-2016 (K Doses)

Table United States Production Market Share of Acne Drugs by Type in 2011-2016

Figure United States Production Market Share of Acne Drugs by Type in 2014

Figure United States Production Market Share of Acne Drugs by Type in 2015

Table United States Sales of Acne Drugs by Applications 2011-2016 (K Doses)

Table United States Production Market Share of Acne Drugs by Applications 2011-2016

Figure United States Production Market Share of Acne Drugs by Applications in 2014

Figure United States Production Market Share of Acne Drugs by Applications in 2015

Table Price Comparison of United States Acne Drugs Key Manufacturers in 2015 (USD/Dose)

Table United States Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD) of Acne Drugs 2011-2016

Table United States Consumption Volume of Acne Drugs by Regions 2011-2016 (K Doses)

Table United States Consumption Volume Market Share of Acne Drugs by Regions 2011-2016

Figure United States Consumption Volume Market Share of Acne Drugs by Regions in 2014

Figure United States Consumption Volume Market Share of Acne Drugs by Regions in 2015

Table United States Consumption Value of Acne Drugs by Regions 2011-2016 (M USD)

Table United States Consumption Value Market Share of Acne Drugs by Regions 2011-2016

Figure United States Consumption Value Market Share of Acne Drugs by Regions in 2014

Figure United States Consumption Value Market Share of Acne Drugs by Regions in 2015

Table Consumption Price of Acne Drugs by Regions 2011-2016 (USD/Dose)

Table United States and Major Manufacturers Capacity of Acne Drugs 2011-2016 (K Doses)

Table United States Capacity Market Share of Major Acne Drugs Manufacturers 2011-2016

Table United States and Major Manufacturers Production of Acne Drugs 2011-2016 (K Doses)

Table United States Production Market Share of Major Acne Drugs Manufacturers 2011-2016

Table United States and Major Manufacturers Sales of Acne Drugs 2011-2016 (K Doses)

Table United States Sales Market Share of Major Acne Drugs Manufacturers 2011-2016

Table United States and Major Manufacturers Sales Revenue of Acne Drugs 2011-2016 (M USD)

Table United States Sales Revenue Market Share of Major Acne Drugs Manufacturers 2011-2016

Figure United States Capacity (K Doses), Production (K Doses) and Growth Rate of Acne Drugs 2011-2016

Figure United States Capacity Utilization Rate of Acne Drugs 2011-2016

Figure United States Sales Revenue (M USD) and Growth Rate of Acne Drugs 2011-2016

Figure United States Production Market Share of Major Acne Drugs Manufacturers in 2014

Figure United States Production Market Share of Major Acne Drugs Manufacturers in 2015

Figure United States Sales Market Share of Major Acne Drugs Manufacturers in 2014

Figure United States Sales Market Share of Major Acne Drugs Manufacturers in 2015

Figure United States Sales (K Doses) and Growth Rate of Acne Drugs 2011-2016

Table United States Supply, Consumption and Gap of Acne Drugs 2011-2016 (K Doses)

Table United States Import, Export and Consumption of Acne Drugs 2011-2016 (K Doses)

Table Price of United States Acne Drugs Major Manufacturers 2011-2016 (USD/Dose)

Table Gross Margin of United States Acne Drugs Major Manufacturers 2011-2016

Table United States and Major Manufacturers Revenue of Acne Drugs 2011-2016 (M USD)

Table United States Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Acne Drugs 2011-2016

Table Pfizer Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Acne Drugs Picture and Specifications of Pfizer

Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Pfizer 2011-2016

Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Pfizer 2011-2016

Figure Acne Drugs Production (K Doses) and United States Market Share of Pfizer 2011-2016

Table Pfizer Acne Drugs SWOT Analysis

Table Galderma Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Acne Drugs Picture and Specifications of Galderma

Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Galderma 2011-2016

Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Galderma 2011-2016

Figure Acne Drugs Production (K Doses) and United States Market Share of Galderma 2011-2016

Table Galderma Acne Drugs SWOT Analysis

Table Stiefel Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Acne Drugs Picture and Specifications of Stiefel

Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Stiefel 2011-2016

Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Stiefel 2011-2016

Figure Acne Drugs Production (K Doses) and United States Market Share of Stiefel 2011-2016

Table Stiefel Acne Drugs SWOT Analysis

Table Valeant Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Acne Drugs Picture and Specifications of Valeant

Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Valeant 2011-2016

Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Valeant 2011-2016

Figure Acne Drugs Production (K Doses) and United States Market Share of Valeant 2011-2016

Table Valeant Acne Drugs SWOT Analysis

Table Bayer HealthCare Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Acne Drugs Picture and Specifications of Bayer HealthCare

Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Bayer HealthCare 2011-2016

Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Bayer HealthCare 2011-2016

Figure Acne Drugs Production (K Doses) and United States Market Share of Bayer HealthCare 2011-2016

Table Bayer HealthCare Acne Drugs SWOT Analysis

Table AndroScience Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Acne Drugs Picture and Specifications of AndroScience

Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of AndroScience 2011-2016

Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of AndroScience 2011-2016

Figure Acne Drugs Production (K Doses) and United States Market Share of AndroScience 2011-2016

Table AndroScience Acne Drugs SWOT Analysis

Table GlaxoSmithKline Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Acne Drugs Picture and Specifications of GlaxoSmithKline

Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of GlaxoSmithKline 2011-2016

Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of GlaxoSmithKline 2011-2016

Figure Acne Drugs Production (K Doses) and United States Market Share of GlaxoSmithKline 2011-2016

Table GlaxoSmithKline Acne Drugs SWOT Analysis

Table Johnson & Johnson Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Acne Drugs Picture and Specifications of Johnson & Johnson

Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Johnson & Johnson 2011-2016

Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Johnson & Johnson 2011-2016

Figure Acne Drugs Production (K Doses) and United States Market Share of Johnson & Johnson 2011-2016

Table Johnson & Johnson Acne Drugs SWOT Analysis

Table Roche Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Acne Drugs Picture and Specifications of Roche

Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Roche 2011-2016

Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Roche 2011-2016

Figure Acne Drugs Production (K Doses) and United States Market Share of Roche 2011-2016

Table Roche Acne Drugs SWOT Analysis

Table Foamix Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Acne Drugs Picture and Specifications of Foamix

Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Foamix 2011-2016

Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Foamix 2011-2016

Figure Acne Drugs Production (K Doses) and United States Market Share of Foamix 2011-2016

Table Foamix Acne Drugs SWOT Analysis

Table Promius Pharma Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Acne Drugs Picture and Specifications of Promius Pharma

Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Promius Pharma 2011-2016

Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Promius Pharma 2011-2016

Figure Acne Drugs Production (K Doses) and United States Market Share of Promius Pharma 2011-2016

Table Promius Pharma Acne Drugs SWOT Analysis

Table Teva Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Acne Drugs Picture and Specifications of Teva

Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Teva 2011-2016

Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Teva 2011-2016

Figure Acne Drugs Production (K Doses) and United States Market Share of Teva 2011-2016

Table Teva Acne Drugs SWOT Analysis

Table Roche Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Acne Drugs Picture and Specifications of Roche

Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Roche 2011-2016

Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Roche 2011-2016

Figure Acne Drugs Production (K Doses) and United States Market Share of Roche 2011-2016

Table Roche Acne Drugs SWOT Analysis

Table Anterios Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Acne Drugs Picture and Specifications of Anterios

Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Anterios 2011-2016

Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Anterios 2011-2016

Figure Acne Drugs Production (K Doses) and United States Market Share of Anterios 2011-2016

Table Anterios Acne Drugs SWOT Analysis

Table Aqua Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Acne Drugs Picture and Specifications of Aqua Pharmaceuticals

Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Aqua Pharmaceuticals 2011-2016

Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Aqua Pharmaceuticals 2011-2016

Figure Acne Drugs Production (K Doses) and United States Market Share of Aqua Pharmaceuticals 2011-2016

Table Aqua Pharmaceuticals Acne Drugs SWOT Analysis

Table Astellas Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Acne Drugs Picture and Specifications of Astellas

Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Astellas 2011-2016

Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Astellas 2011-2016

Figure Acne Drugs Production (K Doses) and United States Market Share of Astellas 2011-2016

Table Astellas Acne Drugs SWOT Analysis

Table BioPharmX Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Acne Drugs Picture and Specifications of BioPharmX

Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of BioPharmX 2011-2016

Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of BioPharmX 2011-2016

Figure Acne Drugs Production (K Doses) and United States Market Share of BioPharmX 2011-2016

Table BioPharmX Acne Drugs SWOT Analysis

Table Celtaxsys Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Acne Drugs Picture and Specifications of Celtaxsys

Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Celtaxsys 2011-2016

Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Celtaxsys 2011-2016

Figure Acne Drugs Production (K Doses) and United States Market Share of Celtaxsys 2011-2016

Table Celtaxsys Acne Drugs SWOT Analysis

Table Cipher Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Acne Drugs Picture and Specifications of Cipher Pharmaceuticals

Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Cipher Pharmaceuticals 2011-2016

Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Cipher Pharmaceuticals 2011-2016

Figure Acne Drugs Production (K Doses) and United States Market Share of Cipher Pharmaceuticals 2011-2016

Table Cipher Pharmaceuticals Acne Drugs SWOT Analysis

Table COSMO Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Acne Drugs Picture and Specifications of COSMO Pharmaceuticals

Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of COSMO Pharmaceuticals 2011-2016

Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of COSMO Pharmaceuticals 2011-2016

Figure Acne Drugs Production (K Doses) and United States Market Share of COSMO Pharmaceuticals 2011-2016

Table COSMO Pharmaceuticals Acne Drugs SWOT Analysis

Table Dermira Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Acne Drugs Picture and Specifications of Dermira

Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Dermira 2011-2016

Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Dermira 2011-2016

Figure Acne Drugs Production (K Doses) and United States Market Share of Dermira 2011-2016

Table Dermira Acne Drugs SWOT Analysis

Table Elorac Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Acne Drugs Picture and Specifications of Elorac

Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Elorac 2011-2016

Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Elorac 2011-2016

Figure Acne Drugs Production (K Doses) and United States Market Share of Elorac 2011-2016

Table Elorac Acne Drugs SWOT Analysis

Table Guthy-Renker Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Acne Drugs Picture and Specifications of Guthy-Renker

Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Guthy-Renker 2011-2016

Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Guthy-Renker 2011-2016

Figure Acne Drugs Production (K Doses) and United States Market Share of Guthy-Renker 2011-2016

Table Guthy-Renker Acne Drugs SWOT Analysis

Table Helix BioMedix Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Acne Drugs Picture and Specifications of Helix BioMedix

Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Helix BioMedix 2011-2016

Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Helix BioMedix 2011-2016

Figure Acne Drugs Production (K Doses) and United States Market Share of Helix BioMedix 2011-2016

Table Helix BioMedix Acne Drugs SWOT Analysis

Table Hygeia Therapeutics Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Acne Drugs Picture and Specifications of Hygeia Therapeutics

Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Hygeia Therapeutics 2011-2016

Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Hygeia Therapeutics 2011-2016

Figure Acne Drugs Production (K Doses) and United States Market Share of Hygeia Therapeutics 2011-2016

Table Hygeia Therapeutics Acne Drugs SWOT Analysis

Table Meda Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Acne Drugs Picture and Specifications of Meda

Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Meda 2011-2016

Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Meda 2011-2016

Figure Acne Drugs Production (K Doses) and United States Market Share of Meda 2011-2016

Table Meda Acne Drugs SWOT Analysis

Table Mylan Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Acne Drugs Picture and Specifications of Mylan

Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Mylan 2011-2016

Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Mylan 2011-2016

Figure Acne Drugs Production (K Doses) and United States Market Share of Mylan 2011-2016

Table Mylan Acne Drugs SWOT Analysis

Table Novan Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Acne Drugs Picture and Specifications of Novan

Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Novan 2011-2016

Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Novan 2011-2016

Figure Acne Drugs Production (K Doses) and United States Market Share of Novan 2011-2016

Table Novan Acne Drugs SWOT Analysis

Table Oculus Innovative Sciences Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Acne Drugs Picture and Specifications of Oculus Innovative Sciences

Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Oculus Innovative Sciences 2011-2016

Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Oculus Innovative Sciences 2011-2016

Figure Acne Drugs Production (K Doses) and United States Market Share of Oculus Innovative Sciences 2011-2016

Table Oculus Innovative Sciences Acne Drugs SWOT Analysis

Table Paratek Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Acne Drugs Picture and Specifications of Paratek Pharmaceuticals

Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Paratek Pharmaceuticals 2011-2016

Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Paratek Pharmaceuticals 2011-2016

Figure Acne Drugs Production (K Doses) and United States Market Share of Paratek Pharmaceuticals 2011-2016

Table Paratek Pharmaceuticals Acne Drugs SWOT Analysis

Table Photocure Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Acne Drugs Picture and Specifications of Photocure

Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Photocure 2011-2016

Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Photocure 2011-2016

Figure Acne Drugs Production (K Doses) and United States Market Share of Photocure 2011-2016

Table Photocure Acne Drugs SWOT Analysis

Table Ranbaxy Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Acne Drugs Picture and Specifications of Ranbaxy

Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Ranbaxy 2011-2016

Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Ranbaxy 2011-2016

Figure Acne Drugs Production (K Doses) and United States Market Share of Ranbaxy 2011-2016

Table Ranbaxy Acne Drugs SWOT Analysis

Table Reckitt Benckiser Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Acne Drugs Picture and Specifications of Reckitt Benckiser

Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Reckitt Benckiser 2011-2016

Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Reckitt Benckiser 2011-2016

Figure Acne Drugs Production (K Doses) and United States Market Share of Reckitt Benckiser 2011-2016

Table Reckitt Benckiser Acne Drugs SWOT Analysis

Table Skinvisible Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Acne Drugs Picture and Specifications of Skinvisible Pharmaceuticals

Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Skinvisible Pharmaceuticals 2011-2016

Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Skinvisible Pharmaceuticals 2011-2016

Figure Acne Drugs Production (K Doses) and United States Market Share of Skinvisible Pharmaceuticals 2011-2016

Table Skinvisible Pharmaceuticals Acne Drugs SWOT Analysis

Table Versapharm Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Acne Drugs Picture and Specifications of Versapharm

Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Versapharm 2011-2016

Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Versapharm 2011-2016

Figure Acne Drugs Production (K Doses) and United States Market Share of Versapharm 2011-2016

Table Versapharm Acne Drugs SWOT Analysis

Table XBiotech Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Acne Drugs Picture and Specifications of XBiotech

Table Acne Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of XBiotech 2011-2016

Figure Acne Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of XBiotech 2011-2016

Figure Acne Drugs Production (K Doses) and United States Market Share of XBiotech 2011-2016

Table XBiotech Acne Drugs SWOT Analysis

Table Acne Drugs Price by Regions 2011-2016

Table Acne Drugs Price by Product Types 2011-2016

Table Acne Drugs Price by Companies 2011-2016

Table Acne Drugs Gross Margin by Companies 2011-2016

Table Price Comparison of Acne Drugs by Regions 2011-2016 (USD/Dose)

Table Price of Different Acne Drugs Product Types (USD/Dose)

Table Market Share of Different Acne Drugs Price Level

Table Gross Margin of Different Acne Drugs Applications

Table Marketing Channels Status of Acne Drugs

Table Traders or Distributors of Acne Drugs with Contact Information

Table Ex-work Price, Channel Price and End Buyer Price of Acne Drugs (USD/Dose) in 2015

Table United States Import, Export, and Trade of Acne Drugs (K Doses)

Figure United States Capacity (K Doses), Production (K Doses) and Growth Rate of Acne Drugs 2016-2021

Figure United States Capacity Utilization Rate of Acne Drugs 2016-2021

Table United States Acne Drugs Production by Type 2016-2021 (K Doses)

Table United States Acne Drugs Production Market Share by Type 2016-2021

Figure United States Production Market Share of Acne Drugs by Type in 2021

Figure United States Sales (K Doses) and Growth Rate of Acne Drugs 2016-2021

Figure United States Sales Revenue (Million USD) and Growth Rate of Acne Drugs 2016-2021

Figure United States Sales of Acne Drugs by Applications 2016-2021 (K Doses)

Table United States Production Market Share of Acne Drugs by Applications 2016-2021

Figure United States Production Market Share of Acne Drugs by Applications in 2021

Table United States Production, Import, Export and Consumption of Acne Drugs 2016-2021 (K Doses)

Table United States Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Acne Drugs 2016-2021

Table Major Raw Materials Suppliers of Acne Drugs with Contact Information

Table Manufacturing Equipment Suppliers of Acne Drugs with Contact Information

Table Major Players of Acne Drugs with Contact Information

Table Key Consumers of Acne Drugs with Contact Information

Table Supply Chain Relationship Analysis of Acne Drugs

Table New Project SWOT Analysis of Acne Drugs

Table New Project Investment Feasibility Analysis of Acne Drugs

Table Part of Interviewees Record List